MTOR and lung disorder: Results from patient clinicopathological examination and experiments using a mouse model indicated an involvement of alveolar epithelial injury, via local and systemic lipid metabolic stress, in the pathogenesis of mTOR inhibitor-induced lung diseases (29), which may or may not differ from that induced by immune checkpoint inhibitors.